Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study. by Reginster, J, Adami, S, Lakatos, P, Greenwald, M, Stepan, J, Silverman, S, Christiansen, C, Rowell, L, Mairon, N, Bonvoisin, B, Drezner, M, Emkey, R, Felsenberg, D, Cooper, C, Delmas, P, Miller, P